// App-Quantinova.ai

e21001 : OrienX010 oncolytic viral therapy in phase a b trial of intralesional injection in unresected stage ac to a acral melanoma patients in China.

Researchers

Presenter

  • Chuanliang Cui

Principal Investigators

  • Zhihong Chi

  • Lu Si

  • Xinan Sheng

  • Dan Li

  • Xuan Wang

  • BIN LIAN

  • Bixia Tang

  • Li Li Mao

  • Xieqiao Yan

  • Li Zhou

  • Xue Bai

  • Jun Guo

Medical Centers

  • Peking University Cancer Hospital & Institute, Beijing, China

  • Peking University Cancer Hospital & Institute, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • OrienX010

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved